These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 288495)

  • 1. Busulphan haemorrhagic cystitis.
    Millard RJ
    Br J Urol; 1978 May; 50(3):210. PubMed ID: 288495
    [No Abstract]   [Full Text] [Related]  

  • 2. Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.
    Thomas AE; Patterson J; Prentice HG; Brenner MK; Ganczakowski M; Hancock JF; Pattinson JK; Blacklock HA; Hopewell JP
    Bone Marrow Transplant; 1987 Apr; 1(4):347-55. PubMed ID: 3139113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Busulfan-induced hemorrhagic cystitis.
    Pode D; Perlberg S; Steiner D
    J Urol; 1983 Aug; 130(2):347-8. PubMed ID: 6576177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation.
    Morgan M; Dodds A; Atkinson K; Szer J; Downs K; Biggs J
    Br J Haematol; 1991 Apr; 77(4):529-34. PubMed ID: 2025579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis.
    Atkinson K; Biggs J; Noble G; Ashby M; Concannon A; Dodds A
    Bone Marrow Transplant; 1987 Dec; 2(4):385-94. PubMed ID: 3332186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remission induction in chronic granulocytic leukaemia using intermittent high-dose busulphan.
    Douglas ID; Wiltshaw E
    Br J Haematol; 1978 Sep; 40(1):59-64. PubMed ID: 280361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Jaundice after treatment of leukemia with busulphan.
    Underwood JC; Shahani RT; Blackburn EK
    Br Med J; 1971 Mar; 1(5748):556-7. PubMed ID: 5280623
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic granulocytic leukaemia with repeated single doses of busulphan.
    Vicariot M; Goldman JM; Catovsky D; Galton DA
    Eur J Cancer (1965); 1979 Apr; 15(4):559-63. PubMed ID: 285861
    [No Abstract]   [Full Text] [Related]  

  • 9. Portal hypertension in a patient with chronic myeloid leukaemia.
    Foadi MD; Shaw S; Paradinas FJ
    Postgrad Med J; 1977 May; 53(619):267-9. PubMed ID: 267281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Busulphan lung in childhood.
    Oakhill A; Green ID; Knowlson GT; Cameron AH; Shah KJ; Hill FG; Mann JR
    J Clin Pathol; 1981 May; 34(5):495-500. PubMed ID: 6941971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Busulphan and the lungs. Absence of lung function disturbance in patients treated with busulphan.
    Comhaire F; Van Hove W; Van Ganse W; Van der Straeten M
    Scand J Respir Dis; 1972; 53(5):265-73. PubMed ID: 4508954
    [No Abstract]   [Full Text] [Related]  

  • 12. Chronic granulocytic leukaemia. Comparison of uracil mustard and busulphan.
    Herrmann RP; Dougan L; Holt JA; Jackson JM; Matthews ML; Nelson AJ; Stenhouse NS; Woodliff HJ
    Med J Aust; 1972 Apr; 1(16):789-91. PubMed ID: 4503393
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapy of chronic granulocytic leukemia.
    Crosby WH
    Arch Intern Med; 1977 Dec; 137(12):1717-8. PubMed ID: 270965
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of chronic myelocytic leukemia.
    Galton DA
    Semin Hematol; 1969 Oct; 6(4):323-43. PubMed ID: 4900650
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic granulocytic leukaemia with Ph 1 negative cells in bone marrow and a ten year remission after busulphan hypoplasia.
    Finney R; McDonald GA; Baikie AG; Douglas AS
    Br J Haematol; 1972 Sep; 23(3):283-8. PubMed ID: 4507535
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pulmonary fibrosis after busulfan therapy].
    Jandl H; Franke A; Albrecht G
    Z Gesamte Inn Med; 1975 Dec; 30(24):799-801. PubMed ID: 1062873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Busulphan lung.
    Woodliff HJ; Finlay-Jones LR
    Med J Aust; 1972 Sep; 2(13):719-22. PubMed ID: 4507947
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chromosome aberrations in busulphan therapy (author's transl)].
    Gebhart E; Schwanitz G; Hartwich G
    Dtsch Med Wochenschr; 1974 Jan; 99(2):52-56. PubMed ID: 4520646
    [No Abstract]   [Full Text] [Related]  

  • 19. Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia.
    Key NS; Kelly PM; Emerson PM; Chapman RW; Allan NC; McGee JO
    Lancet; 1987 Nov; 2(8567):1050-2. PubMed ID: 2889964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocardial fibrosis following busulfan treatment.
    Weinberger A; Pinkhas J; Sandbank U; Shaklai M; de Vries A
    JAMA; 1975 Feb; 231(5):495. PubMed ID: 1054099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.